首页> 美国卫生研究院文献>other >Architecture of P2Y Nucleotide Receptors: Structural Comparison Based on Sequence Analysis Mutagenesis and Homology Modeling
【2h】

Architecture of P2Y Nucleotide Receptors: Structural Comparison Based on Sequence Analysis Mutagenesis and Homology Modeling

机译:P2Y核苷酸受体的体系结构:基于序列分析诱变和同源性建模的结构比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Human P2Y receptors encompass at least eight subtypes of Class A G protein-coupled receptors (GPCRs), responding to adenine and/or uracil nucleotides. Using a BLAST search against the Homo sapiens subset of the SWISS–PROT and TrEMBL databases, we identified 68 proteins showing high similarity to P2Y receptors. To address the problem of low sequence identity between rhodopsin and the P2Y receptors, we performed a multiple-sequence alignment of the retrieved proteins and the template bovine rhodopsin, combining manual identification of the transmembrane domains (TMs) with automatic techniques. The resulting phylogenetic tree delineated two distinct subgroups of P2Y receptors: Gq-coupled subtypes (e.g., P2Y1) and those coupled to Gi (e.g., P2Y12). On the basis of sequence comparison we mutated three Tyr residues of the putative P2Y1 binding pocket to Ala and Phe and characterized pharmacologically the mutant receptors expressed in COS-7 cells. The mutation of Y306 (7.35, site of a cationic residue in P2Y12) or Y203 in the second extracellular loop selectively decreased the affinity of the agonist 2-MeSADP, and the Y306F mutation also reduced antagonist (MRS2179) affinity by 5-fold. The Y273A (6.48) mutation precluded the receptor activation without a major effect on the ligand-binding affinities, but the Y273F mutant receptor still activated G proteins with full agonist affinity. Thus, we have identified new recognition elements to further define the P2Y1 binding site and related these to other P2Y receptor subtypes. Following sequence-based secondary-structure prediction, we constructed complete models of all the human P2Y receptors by homology to rhodopsin. Ligand docking on P2Y1 and P2Y12 receptor models was guided by mutagenesis results, to identify the residues implicated in the binding process. Different sets of cationic residues in the two subgroups appeared to coordinate phosphate-bearing ligands. Within the P2Y1 subgroup these residues are R3.29, K/R6.55, and R7.39. Within the P2Y12 subgroup, the only residue in common with P2Y1 is R6.55, and the role of R3.29 in TM3 seems to be fulfilled by a Lys residue in EL2, whereas the R7.39 in TM7 seems to be substituted by K7.35. Thus, we have identified common and distinguishing features of P2Y receptor structure and have proposed modes of ligand binding for the two representative subtypes that already have well-developed ligands.
机译:人类P2Y受体包含至少8种A类G蛋白偶联受体(GPCR)亚型,对腺嘌呤和/或尿嘧啶核苷酸有反应。通过对SWISS–PROT和TrEMBL数据库的智人子集进行BLAST搜索,我们鉴定出68种蛋白与P2Y受体具有高度相似性。为了解决视紫红质和P2Y受体之间的低序列同一性的问题,我们将检索到的蛋白质与模板牛视紫红质进行了多序列比对,结合了跨膜域(TMs)的手动识别和自动技术。形成的系统树描述了P2Y受体的两个不同亚组:Gq偶联亚型(例如P2Y1)和与Gi偶联的亚型(例如P2Y12)。在序列比较的基础上,我们将推定的P2Y1结合口袋的三个Tyr残基突变为Ala和Phe,并在药理上表征了在COS-7细胞中表达的突变受体。第二个胞外环中的Y306突变(7.35,P2Y12中一个阳离子残基的位点)或Y203的突变选择性降低了激动剂2-MeSADP的亲和力,Y306F突变也使拮抗剂(MRS2179)亲和力降低了5倍。 Y273A(6.48)突变排除了受体激活,而对配体结合亲和力没有重大影响,但是Y273F突变受体仍激活了具有完全激动剂亲和力的G蛋白。因此,我们确定了新的识别元件,以进一步定义P2Y1结合位点,并将其与其他P2Y受体亚型相关。根据基于序列的二级结构预测,我们通过与视紫红质的同源性构建了所有人类P2Y受体的完整模型。诱变结果指导配体在P2Y1和P2Y12受体模型上的对接,以鉴定与结合过程有关的残基。两个亚组中不同组的阳离子残基似乎可以配位含磷酸盐的配体。在P2Y1子组中,这些残基为R3.29,K / R6.55和R7.39。在P2Y12子组中,与P2Y1唯一相同的残基是R6.55,而TM3中的R3.29的作用似乎由EL2中的Lys残基完成,而TM7中的R7.39似乎被K7取代。 .35。因此,我们已经确定了P2Y受体结构的共同特征和区别特征,并针对已经具有良好配体的两种代表性亚型提出了配体结合模式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号